PL155410B1 - Method of obtaining lymphotoxins - Google Patents

Method of obtaining lymphotoxins

Info

Publication number
PL155410B1
PL155410B1 PL1985253739A PL25373985A PL155410B1 PL 155410 B1 PL155410 B1 PL 155410B1 PL 1985253739 A PL1985253739 A PL 1985253739A PL 25373985 A PL25373985 A PL 25373985A PL 155410 B1 PL155410 B1 PL 155410B1
Authority
PL
Poland
Prior art keywords
leu
pro
cheese
ala
gly
Prior art date
Application number
PL1985253739A
Other languages
English (en)
Polish (pl)
Other versions
PL253739A1 (en
Inventor
Bharat B Aggarwal
Timothy S Bringman
Patrick W Gray
Glenn E Nedwin
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/616,502 external-priority patent/US4959457A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PL253739A1 publication Critical patent/PL253739A1/xx
Publication of PL155410B1 publication Critical patent/PL155410B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C07K16/242—Lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL1985253739A 1984-05-31 1985-05-31 Method of obtaining lymphotoxins PL155410B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61650384A 1984-05-31 1984-05-31
US06/616,502 US4959457A (en) 1984-05-31 1984-05-31 Anti-lymphotoxin
US73231285A 1985-05-09 1985-05-09

Publications (2)

Publication Number Publication Date
PL253739A1 PL253739A1 (en) 1986-03-11
PL155410B1 true PL155410B1 (en) 1991-11-29

Family

ID=27417179

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1985253739A PL155410B1 (en) 1984-05-31 1985-05-31 Method of obtaining lymphotoxins

Country Status (23)

Country Link
EP (2) EP0509553B1 (enExample)
JP (3) JP2521703B2 (enExample)
AR (1) AR245219A1 (enExample)
AT (2) ATE195323T1 (enExample)
AU (1) AU599303B2 (enExample)
BG (1) BG60256B2 (enExample)
CA (1) CA1340641C (enExample)
CZ (1) CZ283148B6 (enExample)
DE (2) DE3588225T2 (enExample)
DK (1) DK171531B1 (enExample)
ES (1) ES8802182A1 (enExample)
FI (1) FI93025C (enExample)
GR (1) GR851317B (enExample)
HU (1) HU204085B (enExample)
IE (1) IE63487B1 (enExample)
IL (1) IL75318A (enExample)
NO (1) NO179075C (enExample)
NZ (1) NZ212207A (enExample)
PL (1) PL155410B1 (enExample)
PT (1) PT80573B (enExample)
RO (1) RO100383A2 (enExample)
SK (1) SK393085A3 (enExample)
YU (1) YU47735B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041313B1 (en) 1980-04-03 1990-09-12 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
EP0368367A1 (en) * 1984-12-21 1990-05-16 Biogen, Inc. Purification, production and use of tumor necrosis factors
JPS62195285A (ja) * 1986-02-19 1987-08-28 Kanegafuchi Chem Ind Co Ltd リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法
JPS62111928A (ja) * 1985-10-15 1987-05-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン
AU603768B2 (en) * 1985-07-04 1990-11-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
JP2548204B2 (ja) * 1987-06-27 1996-10-30 電気化学工業株式会社 新生理活性ポリペプチド
DE3686148T2 (de) * 1985-12-24 1993-01-14 Denki Kagaku Kogyo Kk Lymphotoxin-gen, verfahren zu dessen herstellung und lymphotoxin.
US5403725A (en) * 1985-12-24 1995-04-04 Denki Kagaku Kogyo Kabushiki Kaisha Method for production of lymphotoxin (TNFB) in cell line A-C5-8
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
JPS63105680A (ja) * 1986-10-22 1988-05-10 Kanegafuchi Chem Ind Co Ltd ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法
EP0272894A3 (en) * 1986-12-24 1989-06-14 Takeda Chemical Industries, Ltd. Recombinant human lymphotoxin
US5175268A (en) * 1986-12-24 1992-12-29 Takeda Chemical Industries, Ltd. DNA encoding recombinant human lymphotoxin
FI884798A7 (fi) * 1987-10-28 1989-04-29 Eisai Co Ltd Rekombinantlymfotoxin.
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
GB2217326B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene encoding human tumour necrosis factor beta.
EP0338497A3 (en) * 1988-04-22 1990-05-16 Takeda Chemical Industries, Ltd. Bispecific hybrid monoclonal antibody
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
CA2001756A1 (en) * 1988-10-31 1991-04-30 Seiichi Uesugi New human lymphotoxin n-end deletion mutant
JPH03106821A (ja) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk 抗腫瘍剤
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
JP4231106B2 (ja) * 1995-01-23 2009-02-25 ゼノテック インコーポレイティッド 骨溶解および転移を改善する方法
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
JP2002508962A (ja) 1998-01-15 2002-03-26 ジェネンテク・インコーポレイテッド Ａｐｏ−２リガンド
JP2011516026A (ja) * 2002-11-26 2011-05-26 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための組成物と方法
NZ544924A (en) 2003-06-27 2009-03-31 Biogen Idec Inc Modified binding molecules comprising connecting peptides
EP1699486A4 (en) * 2003-12-08 2007-07-18 Centocor Inc ANTI-LYMPHOTOXIN HUMAN ALPHA ANTIBODIES, COMPOSITIONS, METHODS AND USES
KR20060132006A (ko) 2004-03-23 2006-12-20 비오겐 아이덱 엠에이 아이엔씨. 수용체 커플링제 및 이의 치료적 용도
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
UA94484C2 (uk) * 2006-10-12 2011-05-10 Дженентек, Інк. Антитіла до лімфотоксину-альфа
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
CN101600450A (zh) 2006-10-20 2009-12-09 比奥根艾迪克Ma公司 利用可溶性淋巴毒素β受体的脱髓鞘病的治疗
JP6702883B2 (ja) * 2014-04-25 2020-06-03 ノーレックス インコーポレイテッド 向神経活性ペプチドの安定な組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU88258I2 (enExample) * 1978-12-22 1994-02-03
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
DE3331108A1 (de) * 1983-08-30 1985-05-02 Boehringer Ingelheim International GmbH, 6507 Ingelheim Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin

Also Published As

Publication number Publication date
EP0164965A3 (en) 1988-04-06
JPH07291995A (ja) 1995-11-07
PT80573A (en) 1985-06-01
JP2521703B2 (ja) 1996-08-07
CZ283148B6 (cs) 1998-01-14
JP2804237B2 (ja) 1998-09-24
ATE95243T1 (de) 1993-10-15
DE3587597T2 (de) 1994-06-01
IE63487B1 (en) 1995-05-03
AU599303B2 (en) 1990-07-19
FI93025B (fi) 1994-10-31
EP0509553B1 (en) 2000-08-09
IE851321L (en) 1985-11-30
NZ212207A (en) 1991-07-26
ATE195323T1 (de) 2000-08-15
CA1340641C (en) 1999-07-13
EP0164965B1 (en) 1993-09-29
IL75318A (en) 1994-08-26
DK171531B1 (da) 1996-12-23
PT80573B (pt) 1987-08-19
YU47735B (sh) 1996-01-08
DE3588225T2 (de) 2001-04-05
CZ393085A3 (en) 1997-07-16
DE3587597D1 (de) 1993-11-04
RO100383B1 (ro) 1991-03-01
AU4320385A (en) 1985-12-05
BG60256B1 (bg) 1994-03-24
JPH07250692A (ja) 1995-10-03
RO100383A2 (ro) 1991-10-17
BG60256B2 (bg) 1994-03-24
IL75318A0 (en) 1985-09-29
PL253739A1 (en) 1986-03-11
SK278333B6 (en) 1996-11-06
SK393085A3 (en) 1996-11-06
DK241385A (da) 1985-12-01
ES543695A0 (es) 1988-04-16
IE930589L (en) 1985-11-30
GR851317B (enExample) 1985-11-25
FI852143A0 (fi) 1985-05-29
NO179075B (no) 1996-04-22
AR245219A1 (es) 1993-12-30
FI852143L (fi) 1985-12-01
HUT37814A (en) 1986-02-28
EP0509553A1 (en) 1992-10-21
JPS6156197A (ja) 1986-03-20
YU91985A (en) 1988-12-31
NO852173L (no) 1985-12-02
FI93025C (fi) 1995-02-10
HU204085B (en) 1991-11-28
ES8802182A1 (es) 1988-04-16
DK241385D0 (da) 1985-05-30
NO179075C (no) 1996-07-31
DE3588225D1 (de) 2000-09-14
EP0164965A2 (en) 1985-12-18

Similar Documents

Publication Publication Date Title
PL155410B1 (en) Method of obtaining lymphotoxins
JP2614989B2 (ja) 腫瘍壊死因子含有組成物
US5639455A (en) Immunosuppressant
IE61773B1 (en) Novel lymphokine related peptides
JPH06505631A (ja) 巨核球刺激因子
EP0357067B1 (en) Recombinant natural killer cell activator
US5683688A (en) Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US4959457A (en) Anti-lymphotoxin
WO2005021578A2 (en) A novel chimeric polypeptide and use thereof
AU654142B2 (en) Stable and bioactive modified somatotropins
NZ226980A (en) Lymphotoxin-neutralising antibody and its use in separating out lymphotoxin from a composition
DK172382B1 (da) Rekombinante lymphotoxinderivater
IL104297A (en) Lymphotoxin Nucleic acid encoding vectors containing the nucleic acid and cells converted by them Methods for obtaining lymphotoxin
JPS63119679A (ja) インヒビンのα鎖またはβ鎖をコ−ドしている核酸、並びにその様な核酸を用いてポリペプチドを合成する方法
JP3534434B2 (ja) トロンボモジュリン類発現用シグナルペプチド
CN101166757A (zh) 新的嵌合多肽及其应用